The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Equip FT

. Suspension for injection

Zoetis Belgium S.A.VPA10387/030/001

Main Information

Trade NameEquip FT
Active SubstancesInactivated equine influenza a newmarket 77 (H7 N7)
Inactivated equine influenza a borlonge 91 (H3 N8)
Inactivated equine influenza a Kentucky 98 (H3 N8)
Tetanus toxoid (immunopurified)
Dosage FormSuspension for injection
Licence HolderZoetis Belgium S.A.
Licence NumberVPA10387/030/001

Group Information

ATC CodeQI05AL01 equine influenza virus + clostridium
Therapeutic ClassImmunological - Inactivated Vaccine


Licence Issued04/07/2014
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back